Humanized Anti-CD26 Monoclonal Antibody Has Anti-Myeloma Efficacy for the Treatment of High-Risk Multiple Myeloma

被引：0
|
作者：
Nishida, Hiroko
Hayashi, Mutsumi
Morimoto, Chikao
Sakamoto, Michiie
Yamada, Taketo
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4424
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors
    Inamoto, Teruo
    Yamada, Taketo
    Ohnuma, Kei
    Kina, Shinichiro
    Takahashi, Nozomu
    Yamochi, Tadanori
    Inamoto, Sakiko
    Katsuoka, Yoji
    Hosono, Osamu
    Tanaka, Hirotoshi
    Dang, Nam H.
    Morimoto, Chikao
    CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4191 - 4200
  • [2] The in vivo antitumor activity of a humanized anti-CD26 monoclonal antibody
    Yeung, Pete
    Sun, Difei
    Banica, Monica
    Williams, Jason
    Cheung, Peter
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3548S - 3549S
  • [3] Humanized Anti-CD26 Monoclonal Antibody Inhibits Osteoclast Bone Resorption Activity Via Blockade Of P38MAPK Signaling In Multiple Myeloma
    Nishida, Hiroko
    Madokoro, Hiroko
    Suzuki, Hiroshi
    Sakamoto, Michiie
    Morimoto, Chikao
    Yamada, Taketo
    BLOOD, 2013, 122 (21)
  • [4] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
    Nishida, Hiroko
    Hayashi, Mutsumi
    Morimoto, Chikao
    Sakamoto, Michiie
    Yamada, Taketo
    BLOOD CANCER JOURNAL, 2018, 8
  • [5] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
    Hiroko Nishida
    Mutsumi Hayashi
    Chikao Morimoto
    Michiie Sakamoto
    Taketo Yamada
    Blood Cancer Journal, 8
  • [6] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
    Richardson, P.
    Lokhorst, H.
    Palumbo, A.
    Nahi, H.
    Laubach, J.
    Gimsing, P.
    Lisby, S.
    Cakana, A.
    Brun, N. Constantin
    Plesner, T.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
  • [7] Novel anti-CD84 humanized monoclonal antibody enhances anti-tumor immunity in multiple myeloma
    Gunes, Metin
    Lewinsky, Hadas
    Dang, Jessica
    Ma, Ning
    Vaidehi, Nagarajan
    Janakiram, Murali
    Feng, Mingye
    Shachar, Idit
    Rosen, Steven
    Gunes, E. Gulsen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S91 - S91
  • [8] Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody
    Hatano, Ryo
    Ohnuma, Kei
    Yamamoto, Junpei
    Dang, Nam H.
    Yamada, Taketo
    Morimoto, Chikao
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (02) : 263 - 277
  • [9] Anti-CD20 monoclonal antibody therapy in multiple myeloma
    Kapoor, Prashant
    Greipp, Patricia T.
    Morice, William G.
    Rajkumar, S. Vincent
    Witzig, Thomas E.
    Greipp, Philip R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) : 135 - 148
  • [10] A humanized anti-CD70 monoclonal antibody targets CD70-expressing multiple myeloma.
    McEarchern, JA
    McDonagh, C
    Ho, A
    Tai, YT
    Francisco, L
    Klussman, K
    Morris-Tilden, C
    Gordon, K
    Oflazoglu, E
    Kissler, K
    Munshi, N
    Anderson, KC
    Treon, SP
    Carter, P
    Wahl, AF
    Grewal, LS
    Law, CL
    BLOOD, 2005, 106 (11) : 456A - 456A
12345